Tuesday, January 12, 2021

Brazil trial finds efficacy of Sinovac vaccine at 50.4 percent

Efficacy rate of China-developed product barely sufficient to secure regulatory approval.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)